Navigation Links
Organovo Reports 2012 Financial Results
Date:3/18/2013

n, or 143%, over 2011 expenses of $1.4 million as the Company increased its research and development staff to support its obligations under certain collaborative research agreements and to expand product development efforts in preparation for research-derived revenues. Full-time research and development staffing increased from eight scientists and engineers as of December 31, 2011 to nineteen as of December 31, 2012.

Selling, General and Administrative Expenses
Selling, general and administrative expenses grew from $1.7 million in 2011 to $7.1 million in 2012, an increase of $5.4 million, or 318%.  This increase was driven by non-recurring charges associated with the Company's financing transactions, increased payroll and facilities expenses and its transition from operating in a private company environment to operating as a publicly-traded corporation. As expected in such transition, incremental initiatives were established in investor outreach, corporate governance, and SEC financial reporting. Non-payroll related incremental public company expenses incurred in 2012 were approximately $3.2 million, including non-recurring charges associated with the Company's reverse merger and financing transactions completed during the year. In addition, expanded staff increased payroll and facilities expenses in 2012 over 2011 levels with general and administrative staff increasing from four full-time employees as of December 31, 2011 to ten full-time employees as of December 31, 2012. This increase was primarily due to the addition of two executive positions and an increase in the accounting and administrative staff. In addition, existing executive officers received salary increases as approved by the Board of Directors, reflecting the increased responsibilities assumed as a result of becoming a publicly-traded company and success on the Company's growth initiatives established by the Board of Directors.

Other Income (Expense)
The $32.2 million increas
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
2. Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research
3. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
4. Organovo Reports Q2 2012 Financial Results, Provides Business Update
5. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
7. Organovo Holdings Appoints James T. Glover to Board of Directors
8. China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012
9. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Addus HomeCare Reports Fourth Quarter 2012 Results Completes Sale of Home Health Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... N.J. , March 5, 2015 Bayer ... dollars to the Conquer Cancer Foundation of the American ... cutting edge health information technology platform designed to unlock ... living with cancer.  "Bayer is proud ... their efforts to leverage Big Data to help people ...
(Date:3/5/2015)... , March 5, 2015   ndd Medical Technologies ... (PFT) that employs precise ultrasound technology, announced that its ... held by the San Antonio Pulmonary Fibrosis Support Group. ... or pulmonary fibrosis (PF), as well as those suspected ... footprint of a mere 12 square inches, EasyOne Pro ...
(Date:3/5/2015)... 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), a ... of chronic pain, today announced the appointment of ... The panel of experts will provide support for ... advance the company pipeline of novel investigational therapies ... a range of areas including opioid receptors, addiction, ...
Breaking Medicine Technology:Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4
... SAN MARINO, Calif., June 04, 2007 /PRNewswire/ -- ... of a historic landmark in medical oncology and ... gene therapy.,The first clinical report of its kind, ... issue of the International Journal of,Oncology, Vol.30, pp. ...
... WIRE)--Jun 5, 2007 - NovaDel Pharma,Inc. (AMEX: ... formulations for a broad range of marketed ... comparing zolpidem,oral spray with zolpidem tablets have ... safety objectives.,Zolpidem tablets are currently marketed as ...
Cached Medicine Technology:News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7
(Date:3/6/2015)... As the Association of American Medical ... doctors by 2025 is updated this week and debated ... proactively preparing by analyzing demographics and pursuing viable solutions ... Several factors including the increasing number of retiring doctors, ... Affordable Care Act and an uneven distribution of new ...
(Date:3/6/2015)... La (PRWEB) March 06, 2015 Many ... function despite medical therapy. If you (or someone you ... to knee osteoarthritis, you may be interested in the ... Covington Orthopedic announced today that he is one of ... Cytori Therapeutics to begin enrolling subjects as part of ...
(Date:3/6/2015)... Utilizing the latest in nutritional science to ... weight has enabled Diet Doc to add powerful new ... collection of fat loss enhancement medications. And now, they ... savings to help people throughout the country begin losing ... especially appealing to new clients because they can receive ...
(Date:3/6/2015)... TX (PRWEB) March 06, 2015 ... publishing company, created a unique ‘energy’ experiment to ... lives. , After quick ‘5 -7 ... more than 150+ countries reported their life improving ... respondents reported positive results. , According to research, ...
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading a three ... for advanced education in the field of dentistry, Spear Education ... a visiting faculty member of this prestigious institution, Dr. Sowell ... visits Spear Education to participate in a specialized workshop. Of ... only the top 10% and those willing to sacrifice to ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 3Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 4Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2
... pounds and considering one of the popular low-carbohydrate diets, along ... of fat in such a program compared to a low-fat, ... new studies by heart and vascular researchers at Johns Hopkins. ... have options when choosing a weight-loss program, including a low-carb ...
... Imaging utilization on stroke patients is affected by age and ... and computed tomography (CT) machines at any given facility, according ... Journal of the American College of Radiology ( www.jacr.org ... health care expenditure growth. Although there are many potential reasons ...
... HealthDay Reporter , TUESDAY, May 31 (HealthDay News) -- Getting ... from premature births and low birth weight babies, a new ... 4,200 births between June 2004 and September 2006 in the ... a flu shot during pregnancy. Pregnant women who received ...
... HealthDay Reporter , TUESDAY, May 31 (HealthDay News) -- ... and an easing of standards for the federally administered Pre-Existing ... insurance. Premiums under the Pre-Existing Condition Insurance Plan, ... as much as 40 percent in 18 states. And standards ...
... Maureen Salamon HealthDay Reporter , TUESDAY, May ... genes, proteins and other so-called "biomarkers" with certain diseases ... Analyzing 35 of the most frequently cited studies published ... study authors found that fewer than half of the ...
... A facelift incision and robotics can help surgeons ... some patients without the characteristic neck scar. Georgia ... remote access capabilities of robots, experience gained from another ... the largest salivary gland from the lower jaw region. ...
Cached Medicine News:Health News:Low-carb, higher-fat diets add no arterial health risks to obese people seeking to lose weight 2Health News:Low-carb, higher-fat diets add no arterial health risks to obese people seeking to lose weight 3Health News:Low-carb, higher-fat diets add no arterial health risks to obese people seeking to lose weight 4Health News:Flu Shot May Lower Odds for Preemie Delivery 2Health News:Flu Shot May Lower Odds for Preemie Delivery 3Health News:U.S. Makes It Easier to Get Insurance With Pre-Existing Conditions 2Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 2Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 3Health News:Facelift incision offers safe option for some thyroid patients 2Health News:Facelift incision offers safe option for some thyroid patients 3
... tissue valve from Medtronic, is the only ... Mosaic valve builds upon three decades of ... choice for patients who require aortic or ... For more than 20 years, Medtronics mitral ...
... Hancock® II bioprosthesis from Medtronic ... of proven clinical experience. Worldwide ... freedom from structural valve deterioration ... mitral bioprostheses is substantially better ...
... bioprosthesis from Medtronic has more ... clinical experience. Worldwide clinical studies ... structural valve deterioration with Hancock® ... is substantially better than results ...
Attain Venogram Balloon Catheter....
Medicine Products: